Opportunity Information: Apply for RFA HL 13 023
Apply for RFA HL 13 023
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Career Development Program in Omics of Lung Diseases (K12)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.838 Lung Diseases Research.
- This funding opportunity was created on Jul 26, 2012 and posted on Jul 26, 2012.
- Applicants must submit their applications by Oct 26, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Career Development Program in Omics of Lung Diseases (K12) is a National Institutes of Health (NIH) training and career development grant opportunity designed to build a structured program that helps early-career investigators become independent researchers in the rapidly expanding area of omics-driven lung disease research. The core purpose is not simply to fund individual projects, but to support an organized, multidisciplinary career development environment where new MD and PhD (or equivalent) investigators gain the practical skills, mentorship, and research experience needed to use modern high-dimensional biological data to answer clinically meaningful questions in pulmonary medicine. At a high level, the program is aimed at accelerating the pipeline of scientists who can move smoothly between computational, molecular, and clinical domains and who can translate large-scale biological measurements into insights that improve understanding of lung disease and support personalized medicine.
Scientifically, the opportunity emphasizes "pan-omics" and integrated approaches, meaning applicants are expected to train scholars to work across multiple layers of biological information rather than relying on a single data type. This includes genomics and other omics modalities, along with analytical strategies that can integrate these measurements to uncover molecular mechanisms of disease. The target outcomes include a deeper understanding of the genomic and molecular bases of lung diseases, an ability to study disease heterogeneity (why patients with the same diagnosis can have very different molecular profiles and outcomes), identification of key regulatory networks (the pathways and interacting biological systems that drive disease processes), and discovery or validation of biomarkers that are relevant for diagnosis, prognosis, or treatment response. The longer-term vision is to push the field toward better mechanistic understanding of lung disease pathobiology and to support future applications of lung disease personalized medicine.
Because the work sits at the intersection of computation and clinical medicine, the announcement makes clear that a successful program needs broad expertise. The training environment is expected to include strong bioinformatics and computational biology capacity, experience working with data from large patient cohorts, and the ability to leverage electronic medical records (EMRs) or related clinical data resources. In addition, the program should provide training in integrative genomics and systems-level analysis approaches, since the point is to connect molecular data to biological processes and clinical phenotypes. At the same time, scholars should have exposure to, or direct involvement in, clinical research and pulmonary medicine so their work remains tied to real lung disease questions, patient populations, and clinically interpretable endpoints.
The mechanism is a K12 institutional career development award, which typically supports an institution-led program that recruits and mentors multiple early-stage scholars under a defined curriculum and mentorship structure. The emphasis here is on building a multidisciplinary training experience, and the announcement explicitly encourages institutions to propose multiple Program Directors/Principal Investigators (PDs/PIs). That detail signals NIH's expectation that leadership may need to be shared across complementary domains (for example, pulmonary/clinical expertise paired with computational genomics leadership) to create a credible program that can train scholars across the full omics-to-clinic pipeline.
In terms of administration and eligibility, the funding opportunity number is RFA-HL-13-023, and it falls under the NIH’s lung diseases research area (CFDA 93.838). It is a discretionary grant program with no cost sharing or matching requirement, which generally lowers barriers for eligible institutions to apply. Eligible applicants include a wide range of U.S.-based organizations such as public and state-controlled institutions of higher education, private institutions of higher education, nonprofits (both with and without 501(c)(3) status, excluding institutions of higher education where specified), Native American tribal governments and tribal organizations, and a variety of designated serving institutions and community-based organizations (including HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian serving institutions, tribally controlled colleges and universities, and U.S. territories or possessions). Foreign institutions are not eligible, and foreign components are not allowed under NIH policy for this announcement, including non-U.S. components of U.S. organizations.
Key dates show that the opportunity was posted on July 26, 2012, with an original and current closing date of October 26, 2012, and it was archived on November 26, 2012. While that means this specific announcement is historical, the summary remains useful as a description of NIH’s goals for building institutional training capacity in omics and lung disease research. For full details, NIH provided an additional information link to the official RFA on the NIH grants site, and a contact route through the NIH Office of Extramural Research (OER) webmaster is included for access or technical issues.
Frequently Asked Questions (FAQs)
What is the Career Development Program in Omics of Lung Diseases (K12)?
The Career Development Program in Omics of Lung Diseases (K12) is an NIH institutional training and career development grant opportunity designed to build a structured program that helps early-career investigators become independent researchers in omics-driven lung disease research.
What is the main purpose of this K12 opportunity?
The core purpose is to support an organized, multidisciplinary career development environment at an institution, rather than simply funding individual research projects. The program is intended to provide practical skills, mentorship, and research experience so participating scholars can use high-dimensional biological data to answer clinically meaningful questions in pulmonary medicine.
Who is this program intended to develop and support?
The program is aimed at early-career investigators, including MD and PhD (or equivalent) researchers, who are working toward becoming independent investigators in the area of omics and lung disease research.
What scientific areas does the program emphasize?
The opportunity emphasizes pan-omics and integrated approaches. Scholars are expected to train across multiple layers of biological information (for example, genomics and other omics modalities) and use analytical strategies that integrate these measurements to understand lung disease biology and clinical phenotypes.
What does "pan-omics" and integrated analysis mean in this context?
In this context, "pan-omics" refers to working across multiple omics data types rather than focusing on a single modality. Integrated analysis refers to methods that combine these different measurements to uncover molecular mechanisms, regulatory networks, and relationships to clinical outcomes or phenotypes.
What outcomes is the program aiming to achieve scientifically?
The target outcomes include deeper understanding of genomic and molecular bases of lung diseases, improved ability to study disease heterogeneity, identification of key regulatory networks, and discovery or validation of biomarkers relevant to diagnosis, prognosis, or treatment response.
How does the program relate to personalized medicine in lung disease?
The longer-term vision is to improve mechanistic understanding of lung disease pathobiology and support future applications of personalized medicine by translating large-scale biological measurements into clinically relevant insights.
What kind of training environment is expected for a successful program?
A successful program is expected to offer broad expertise spanning computational and clinical medicine, including strong bioinformatics and computational biology capacity, experience with large patient cohort data, and the ability to leverage electronic medical records (EMRs) or related clinical data resources.
What types of analytical approaches should scholars be trained in?
The program is expected to provide training in integrative genomics and systems-level analysis approaches, with the goal of connecting molecular data to biological processes and clinical phenotypes.
Is clinical research and pulmonary medicine exposure part of the expectation?
Yes. Scholars should have exposure to, or direct involvement in, clinical research and pulmonary medicine so that research remains grounded in real lung disease questions, patient populations, and clinically interpretable endpoints.
What is the funding mechanism for this opportunity?
This is a K12 institutional career development award mechanism. It typically supports an institution-led program that recruits and mentors multiple early-stage scholars under a defined curriculum and mentorship structure.
Does the opportunity encourage having more than one Program Director/Principal Investigator (PD/PI)?
Yes. The announcement explicitly encourages institutions to propose multiple PDs/PIs, signaling an expectation that leadership may need to be shared across complementary areas such as pulmonary/clinical expertise and computational genomics.
What is the funding opportunity number and NIH research area reference?
The funding opportunity number is RFA-HL-13-023, and it falls under the NIH lung diseases research area with CFDA 93.838.
Is cost sharing or matching required?
No. The announcement specifies that there is no cost sharing or matching requirement.
What types of organizations are eligible to apply?
Eligible applicants include a wide range of U.S.-based organizations such as public and state-controlled institutions of higher education, private institutions of higher education, nonprofits (with or without 501(c)(3) status, as specified), Native American tribal governments and tribal organizations, designated serving institutions (including HBCUs and Hispanic-serving institutions), Alaska Native and Native Hawaiian serving institutions, tribally controlled colleges and universities, community-based organizations, and U.S. territories or possessions.
Are foreign institutions eligible to apply?
No. Foreign institutions are not eligible for this announcement.
Are foreign components allowed as part of an eligible U.S. organization?
No. Foreign components are not allowed under NIH policy for this announcement, including non-U.S. components of U.S. organizations.
When was this funding opportunity posted and when did it close?
The opportunity was posted on July 26, 2012. The original and current closing date was October 26, 2012.
Is this opportunity still active?
No. The announcement was archived on November 26, 2012, which indicates this specific funding opportunity is historical.
If the announcement is archived, why might it still be useful?
Even though the specific announcement is historical, the summary is still useful as a description of NIH goals for building institutional training capacity in omics and lung disease research, especially the emphasis on multidisciplinary training and integration of omics with clinical data.
Where can someone find the official NIH posting and additional details?
NIH provided an additional information link to the official RFA on the NIH grants site for full details.
Who should be contacted for access or technical issues related to the announcement?
A contact route through the NIH Office of Extramural Research (OER) webmaster is included for access or technical issues.
Browse more opportunities from the same category: Health
Next opportunity: Westfield River Westfield Wild and Scenic River Assistance
Previous opportunity: Notice of Intent to Award NOT A REQUEST FOR APPLICATIONS
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HL 13 023
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HL 13 023) also looked into and applied for these:
| Funding Opportunity |
|---|
| Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during the Influenza Season Apply for CDC RFA IP10 0070201SUPP12 Funding Number: CDC RFA IP10 0070201SUPP12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| NIOSH Exploratory/Developmental Grant Program (R21) Apply for PAR 12 252 Funding Number: PAR 12 252 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $275,000 |
| NIOSH Small Research Program (R03) Apply for PAR 12 200 Funding Number: PAR 12 200 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| FY13 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Rhode Island) Apply for PA FPH 13 004 Funding Number: PA FPH 13 004 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $1,138,691 |
| FY13 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Vermont) Apply for PA FPH 13 003 Funding Number: PA FPH 13 003 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $800,329 |
| FY13 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (New Hampshire) Apply for PA FPH 13 002 Funding Number: PA FPH 13 002 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $1,535,898 |
| FY13 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (New Jersey) Apply for PA FPH 13 005 Funding Number: PA FPH 13 005 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $8,968,815 |
| FY13 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Arizona) Apply for PA FPH 13 007 Funding Number: PA FPH 13 007 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $4,955,000 |
| FY13 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (California) Apply for PA FPH 13 008 Funding Number: PA FPH 13 008 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $20,336,320 |
| FY13 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Illinois) Apply for PA FPH 13 006 Funding Number: PA FPH 13 006 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $1,320,307 |
| FY13 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Eastern OK, including the cities of Tulsa and OK City) Apply for PA FPH 13 001 Funding Number: PA FPH 13 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $549,995 |
| FY Announcement of Anticipated Availability of Funds for Family Planning Services Grants (New York City) Apply for PA FPH 13 014 Funding Number: PA FPH 13 014 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $4,075,393 |
| FY13 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Virginia) Apply for PA FPH 13 010 Funding Number: PA FPH 13 010 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $4,499,174 |
| FY13 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Republic of Palau) Apply for PA FPH 13 026 Funding Number: PA FPH 13 026 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $145,000 |
| FY13 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Maryland) Apply for PA FPH 13 009 Funding Number: PA FPH 13 009 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $4,111,717 |
| FY13 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Mississippi) Apply for PA FPH 13 016 Funding Number: PA FPH 13 016 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $4,714,254 |
| FY13 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Southeastern, Pennsylvania) Apply for PA FPH 13 015 Funding Number: PA FPH 13 015 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $5,535,214 |
| FY13 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Navajo Nation) Apply for PA FPH 13 021 Funding Number: PA FPH 13 021 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $528,000 |
| FY13 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Republic of Marshal Islands) Apply for PA FPH 13 025 Funding Number: PA FPH 13 025 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $134,000 |
| FY13 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Guam) Apply for PA FPH 13 024 Funding Number: PA FPH 13 024 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $350,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HL 13 023", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
